Edition:
India

Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results


Thursday, 7 Mar 2019 

March 6 (Reuters) - Adverum Biotechnologies Inc ::ADVERUM BIOTECHNOLOGIES REPORTS FOURTH QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q4 LOSS PER SHARE $0.25.Q4 EARNINGS PER SHARE ESTIMATE $-0.29 -- REFINITIV IBES DATA.EXPECTS YEAR-END CASH POSITION TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURES INTO 2021.ON TRACK TO PROVIDE AN ENROLLMENT UPDATE IN FIRST HALF OF 2019 ON OPTIC PHASE 1 CLINICAL TRIAL OF ADVM-022.ADVERUM BIOTECHNOLOGIES - CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $205.1 MILLION AS OF DEC 31, 2018 VERSUS $217.9 MILLION AS OF SEPT 30, 2018.QTRLY REVENUE, CONSISTING OF REVENUE FROM COLLABORATIVE RESEARCH, WAS $0.1 MILLION VERSUS $0.5 MILLION. 

Company Quote

7.21
 --
22 Oct 2019